Introduction
============

Gastric cancer (GC) originates from the lining of the stomach, and may metastasize to other tissues and organs, including the lungs, liver, lymph nodes and bones ([@b1-ol-0-0-10124]). It is estimated that 22,220 new cases of GC were diagnosed and 10,990 patients succumbed to GC in 2014 ([@b2-ol-0-0-10124]). GC is more common in males, and has a high incidence in East Asia and Eastern Europe ([@b3-ol-0-0-10124]). The most common inducer of GC is *Helicobacter pylori* infection, although other risk factors include pickled foods, smoking and obesity ([@b4-ol-0-0-10124],[@b5-ol-0-0-10124]). Patients with GC usually have an unfavorable prognosis, as the majority reach the advanced stages of disease prior to diagnosis ([@b6-ol-0-0-10124]). Therefore, determining the mechanisms of GC is required for the identification of key biomarkers and the development of effective targeted therapies.

The human genome project indicates that only 1.2% of the mammalian genome encodes proteins ([@b7-ol-0-0-10124]), and that the majority of the genome is transcribed to tens of thousands of long non-coding RNAs (lncRNAs), which are \>200 nt in length ([@b8-ol-0-0-10124]). lncRNAs function in various biological processes, including cellular development and differentiation ([@b9-ol-0-0-10124]). It has increasingly been suggested that the principal role of lncRNAs is the guidance of site specificity for chromatin-modifying complexes in order to effect epigenetic alterations ([@b10-ol-0-0-10124]). lncRNAs act through a number of mechanisms in the control of cancer. For instance, specific lncRNAs are key regulators of the protein signaling pathways underlying carcinogenesis ([@b11-ol-0-0-10124]). Additionally, other lncRNAs function as decoys, sequestering biomolecules and preventing cancerous cells from fulfilling their cellular roles ([@b12-ol-0-0-10124],[@b13-ol-0-0-10124]). Numerous studies have reported the important role of lncRNAs in GC; lncRNA-*H19* is upregulated in GC tissues and affects the progression and metastasis of GC by promoting isthmin 1 expression and inhibiting calneuron 1 expression ([@b14-ol-0-0-10124]). The downregulated expression of lncRNA maternally expressed gene 3 promotes cell proliferation and apoptosis, and predicts a poor prognosis in GC ([@b15-ol-0-0-10124],[@b16-ol-0-0-10124]). Overexpression of the lncRNA colon cancer associated transcript 2 associates with the progression of GC and may serve as a promising prognostic marker for the disease ([@b17-ol-0-0-10124]). Antisense ncRNA in the INK4 locus acts as a growth regulator in GC by silencing microRNA (*miR)-99a* and *miR-449a*, and may indicate a potential prognostic biomarker and therapeutic target in GC ([@b18-ol-0-0-10124],[@b19-ol-0-0-10124]). BRAF-activated non-coding RNA overexpression associates positively with tumor depth, clinical stage and tumor metastasis, and predicts a poor prognosis in patients with GC ([@b20-ol-0-0-10124]). However, the functions of numerous lncRNAs remain unclear; therefore, it is necessary to conduct a comprehensive assessment of the functions of lncRNAs in GC.

Bioinformatics analysis of gene expression profiles has been widely applied to investigate the pathogenesis of various diseases ([@b21-ol-0-0-10124]). In the current study, multiple GC datasets were searched and downloaded from open access databases. Using comprehensive bioinformatics analyses, certain prognosis-associated lncRNAs were identified. An optimal risk score system based on these lncRNAs was constructed to evaluate the risk of developing GC, the efficiency of which was determined using various independent datasets.

Subjects and methods
====================

### Data sources

The mRNA-sequencing data for GC, sequenced on the Illumina HiSeq 2000 RNA Sequencing platform (Illumina, Inc., San Diego, CA, USA), were downloaded from The Cancer Genome Atlas (TCGA; <http://cancergenome.nih.gov/>) database, which included 384 GC samples. Among the 384 samples, there were 122 samples from deceased patients due to GC, 238 samples from surviving patients (mean survival time, mean ± standard deviation, 16.17±16.96 months) and 24 samples without survival information.

From the Gene Expression Omnibus (GEO, <http://www.ncbi.nlm.nih.gov/geo/>) database, three kinds of datasets (dataset I--III) were searched and identified using 'gastric cancer' as the key words. Dataset I was searched according to the following criteria: i) The dataset was a gene expression profile; ii) the samples were tumor tissues from patients with GC; iii) the dataset was a human expression profile; and iv) the total number of samples was ≥100. Thus, GSE15459 ([@b22-ol-0-0-10124]--[@b26-ol-0-0-10124]) (including 300 GC samples) and GSE54129 (including 111 GC samples) sequenced on the Affymetrix-GPL570 platform (Affymetrix; Thermo Fisher Scientific, Inc., Waltham, MA, USA) were selected. The criteria for searching GC dataset II were as follows: i) The dataset was a gene expression profile; ii) the samples were tumor tissues from patients with GC; iii) the dataset was a human expression profile; iv) the samples contained survival information; and v) the total number of samples was ≥100. Only GSE62254 ([@b27-ol-0-0-10124]) (including 300 GC samples; Affymetrix-GPL570 platform; Affymetrix; Thermo Fisher Scientific, Inc.,) was selected, involving 135 samples from deceased patients due to GC, and 148 samples from surviving patients (mean survival time, mean ± standard deviation, 50.59±31.42 months), and 17 samples without survival information. Dataset III was selected according to the following criteria: i) The dataset was a gene expression profile; ii) the samples were tumor tissues from patients with GC; iii) there were control tissues; iv) the dataset was a human expression profile; and v) the total number of samples was ≥50. Ultimately, the GSE65801 ([@b28-ol-0-0-10124]) (including 32 GC samples and 32 control samples; Agilent GPL14550 platform; Agilent Technologies, Inc., Santa Clara, CA, USA), GSE29998 ([@b29-ol-0-0-10124]) (including 50 GC samples and 49 control samples; GPL6947 Illumina HumanHT-12 V3.0 platform; Illumina, Inc.), GSE33335 ([@b30-ol-0-0-10124]--[@b32-ol-0-0-10124]) (including 25 GC samples and 25 control samples; GPL5175 \[HuEx-1_0-st\] platform) and GSE27342 ([@b33-ol-0-0-10124],[@b34-ol-0-0-10124]) (including 80 GC samples and 80 control samples; GPL5175 \[HuEx-1_0-st\] platform) datasets were selected.

### Data preprocessing

The data from the aforementioned databases were divided into three types based on the testing platforms. For the dataset from TCGA, the quantile standardization method in the R package preprocessCore (version 1.40.0; <http://bioconductor.org/packages/release/bioc/html/preprocessCore.html>) ([@b35-ol-0-0-10124]) was used for data normalization. For the CIMFast Event Language data sequenced on the Affymetrix platform, the R package oligo (version 1.41.1; <http://www.bioconductor.org/packages/release/bioc/html/oligo.html>) ([@b36-ol-0-0-10124]) was utilized for format conversion, missing data filling, background correction and data normalization. For the TXT data sequenced on the Agilent platform, the R package Limma (version 3.34.0; <http://bioconductor.org/packages/release/bioc/html/limma.html>) ([@b37-ol-0-0-10124]) was applied for log2 logarithmics and data normalization.

Subsequently, lncRNAs were annotated based on the Ref_seq and Transcript_ID provided by the annotation platform, and aligned with human genome sequences (version, GRCh38) on a platform using Clustal 2.1 software (<http://www.clustal.org/clustal2/>) ([@b38-ol-0-0-10124]). Subsequently, multiple annotation results were merged to identify the lncRNAs and their corresponding expression information ([@b39-ol-0-0-10124]--[@b41-ol-0-0-10124]).

### Weighted gene co-expression network analysis (WGCNA) to identify disease-associated modules

As a bioinformatics algorithm for building co-expression networks, WGCNA is used to identify disease-associated modules and thus screen for pathogenic processes and potential therapeutic targets ([@b42-ol-0-0-10124]). In the present study, based on the use of TCGA dataset as the training dataset, and GSE15459 and GSE54129 as the validation datasets, stable modules associated with GC were identified using the R package WGCNA (version 1.61; <http://cran.r-project.org/web/packages/WGCNA/index.html>) ([@b43-ol-0-0-10124]). Expression correlation between every two of the three datasets was calculated, and the adjacent function was defined as follows: WGCNA analysis was required to satisfy the precondition of scale-free network distribution, and thus the value of the adjacency matrix weighting parameter 'power' was investigated. Based on the RNA data, the squares of the correlation coefficients between log (k) and log \[p (k)\] were calculated for different 'power' values. A higher square value indicated that the network was closer to a scale-free network distribution. Following the definition of the adjacent function, module partition was conducted (the thresholds for module partition were that the module contained ≥150 RNAs and a cutHeight of 0.99). Combined with the clinical information from TCGA dataset, the correlation between each module and the clinical information was analyzed. Functional annotation was conducted for each stable module using the userListEnrichment function in the WGCNA package ([@b43-ol-0-0-10124]). Additionally, differential expression analysis of lncRNAs between tumor and control groups was performed for each module, with a P-value and false discovery rate (FDR) of \<0.05.

### Selection of prognosis-associated lncRNAs

Based on the lncRNAs obtained in the clinical factors-associated stable modules, univariate Cox regression analysis was performed using the R package survival (version 2.4; <http://cran.r-project.org/web/packages/survival/index.html>) ([@b44-ol-0-0-10124]) for the GC samples with survival information in the TCGA dataset, to identify prognosis-associated lncRNAs. A log-rank P-value of \<0.05 was considered to indicate a statistically significant difference.

### Construction and assessment of a risk score system

The lncRNAs in the stable modules that correlated significantly with notable clinical factors were analyzed separately. Using the Cox-Proportional Hazards (Cox-PH) model in the R package 'penalized' (<http://bioconductor.org/packages/penalized/>) ([@b45-ol-0-0-10124]), the optimal lncRNA combinations were selected. The parameter 'lambda' was obtained with 1,000 circulation calculations using a cross-validation likelihood algorithm ([@b46-ol-0-0-10124]). Subsequently, the risk score system was constructed, combined with the regression coefficient (β) and expression level (expr~lncRNA~) of each lncRNA in the optimal lncRNA combination. The risk score of each sample was calculated using the following formula:

Risk score = β ~lncRNA1~ × expr~lncRNA1~ + β ~lncRNA2~ × expr~lncRNA2~ + ··· + β~lncRNAn~ × expr~lncRNAn~.

The samples in the TCGA dataset were divided into high-risk and low-risk groups according to the median of their risk scores. Kaplan-Meier survival curves were used to evaluate the correlation between the overall survival of the samples and the two groups. Using GSE15459 and GSE54129 as the validation datasets, the robustness of the risk score system in predicting sample risk and prognosis was assessed. Moreover, the predictive results of the risk score system in the training and validation datasets were compared to identify the optimal model for subsequent analyses.

### Differential expression analysis of notable lncRNAs in multiple datasets

Using the MetaDE.ES algorithm in the R package MetaDE (version 1.0.5; <http://cran.r-project.org/web/packages/MetaDE/>) ([@b47-ol-0-0-10124],[@b48-ol-0-0-10124]), consensus differentially expressed RNAs (DE-RNAs; between GC and control samples) were screened from the GSE65801, GSE29998, GSE33335 and GSE27342 datasets. τ^2^=0, Qpval\>0.05, P\<0.05 and FDR\<0.05 were set as the cut-off criteria. The focus was the differential expression of the notable lncRNAs that were screened as disease or prognosis related-lncRNAs.

### Analysis of lncRNA-associated pathways

Based on the correlation coefficients between notable lncRNAs and mRNAs that were located in the same WGCNA module, the lncRNA-mRNA network was constructed. Subsequently, pathway enrichment analysis was conducted for the network nodes using Gene Set Enrichment Analysis (GSEA; <http://software.broadinstitute.org/gsea/index.jsp>) ([@b49-ol-0-0-10124]). A nominal P-value of \<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Identification of GC-associated stable modules based on WGCNA

Following data preprocessing, a total of 988 lncRNAs and 15,127 mRNAs shared by TCGA dataset, GSE15459 and GSE54129 were identified. TCGA dataset was taken as the training dataset, whilst GSE15459 and GSE54129 were used as the validation datasets to screen for GC-associated RNA modules.

To ensure that the RNA expression levels in each dataset were comparable, expression consistency analysis was performed for the expression values of shared RNAs. As outlined in [Fig. 1A](#f1-ol-0-0-10124){ref-type="fig"}, the correlation in expression between every two of the three datasets was \>0.85, and P-values were \<1×10^−200^, indicating significant positive correlations between every two datasets and suggesting that these data sets are comparable and suitable for further analysis. Additionally, the correlations of connectivity between nodes were \>0.5, and the P-values were \<1×10^−200^, suggesting that connection correlations between the RNAs of every two datasets were positive ([Fig. 1B](#f1-ol-0-0-10124){ref-type="fig"}).

Following definition of the adjacent function, the power value of 6, for which the square value of the correlation coefficient reached 0.9 for the first time, was selected ([Fig. 2A](#f2-ol-0-0-10124){ref-type="fig"}). Under a power value of 6, the mean connectivity degree of the RNAs was 2, which conformed to the small-world property in a scale-free network ([Fig. 2B](#f2-ol-0-0-10124){ref-type="fig"}).

Following construction of the co-expression network (based on TCGA dataset), the stable modules associated with disease were screened. A total of seven modules (blue, brown, green, grey, red, turquoise and yellow) were obtained ([Fig. 3A](#f3-ol-0-0-10124){ref-type="fig"}). The differentially expressed lncRNAs between the tumor and control groups in the seven modules are listed in [Table I](#tI-ol-0-0-10124){ref-type="table"}. Combined with the seven modules and the RNAs involved in each module, corresponding module partition was conducted in GSE15459 ([Fig. 3B](#f3-ol-0-0-10124){ref-type="fig"}) and GSE54129 ([Fig. 3C](#f3-ol-0-0-10124){ref-type="fig"}).

For TCGA dataset, the module partition and module correlations are presented in [Fig. 4](#f4-ol-0-0-10124){ref-type="fig"}. The results illustrate that the RNAs in the same module tended to cluster together, including the green or blue nodes, indicating that the RNAs have more similar expression levels ([Fig. 4A](#f4-ol-0-0-10124){ref-type="fig"}). The green and blue modules have the characteristics of independent branches ([Fig. 4B](#f4-ol-0-0-10124){ref-type="fig"}).

The stabilities of the seven modules were assessed, and the blue, green, red, turquoise and yellow modules were deemed stable (preservation Z score \>5). The top three modules were turquoise, green and yellow, according to the preservation Z score, and these three may be associated with GC pathogenesis. Functional annotation for each stable module revealed that the lncRNAs in the turquoise (including 46 lncRNAs), green (including 30 lncRNAs) and yellow (including 32 lncRNAs) modules were predominantly enriched in cell adhesion, immune response and digestion, respectively ([Table II](#tII-ol-0-0-10124){ref-type="table"}).

In addition, based on the clinical information in TCGA dataset, the correlation between each module and the clinical factors was analyzed. Among the 5 stable modules, the green and turquoise modules correlated significantly with histological grade ([Fig. 4C](#f4-ol-0-0-10124){ref-type="fig"}). Therefore, the green and turquoise modules were further analyzed.

### Selection of prognosis-associated lncRNAs

Based on the 76 lncRNAs in the green and turquoise modules, 12 prognosis-associated lncRNAs were identified in TCGA dataset using univariate Cox regression analysis. Among the 12 prognosis-associated lncRNAs, 5 belonged to the green module and 7 were from the turquoise module.

### Construction and assessment of risk score system

Based on the expression levels of 12 prognosis-associated lncRNAs in TCGA dataset, the optimal lncRNA combinations that correlated with prognosis were selected using the Cox-PH model. 5-lncRNA, 5-lncRNA and 8-lncRNA ([Table III](#tIII-ol-0-0-10124){ref-type="table"}) optimal combinations were separately screened from the prognosis-associated lncRNAs in the green, turquoise and green + turquoise modules, respectively. The risk score systems based on each optimal lncRNA combination were as follows: Risk score (green module) = (−0.9059377) × Exp~ITPK1-AS1~ + (3.3537827) Exp~KCNQ1DN~ + (−2.1388024) × Exp~LINC00167~ + (−1.037547) × Exp~LINC00173~ + (1.9587271) × Exp~LINC00307~. Risk score (turquoise module)=(−0.268429) × Exp~ASMTL-AS1~ + (−0.3410407) × Exp~CIRBP-AS1~ + (1.0926567) × Exp~DSCR10~ + (−0.3433227) × Exp~JPX~ + (0.5437058) × Exp~LINC00479~. Risk score (green + turquoise module)=(1.9685961) × Exp~KCNQ1DN~ + (−0.6567239) × Exp~LINC00167~ + (−0.4293328) × Exp~LINC00173~ + (−0.246053) × Exp~ASMTL-AS1~ + (−0.25746771) × Exp~CIRBP-AS1~ + (0.7023183) × Exp~DSCR10~ + (−0.3204003) × Exp~JPX~ + (0.5495452) × Exp~LINC00479~.

Based on the three risk score systems, the risk scores of the samples in TCGA dataset were calculated. The samples in the TCGA dataset were divided into high-risk and low-risk groups according to the median of their risk scores. Kaplan-Meier survival curves were used to evaluate the correlation between the overall survival of the samples and the two groups. The results revealed that the risk score system based on the optimal lncRNA combination \[including ITPK1 antisense RNA 1 (*ITPK1-AS1*), KCNQ1 downstream neighbor (*KCNQ1DN*), long intergenic non-protein coding RNA 167 (*LINC00167), LINC00173* and *LINC00307*\] of the green module had the most significant predictive effect; therefore, the risk score system of the green module was the optimal system ([Fig. 5](#f5-ol-0-0-10124){ref-type="fig"}). In this risk score system, the low-risk group (mean overall survival time, 16.71±18.26 months) had a greater overall survival time compared with the high-risk group (mean overall survival time, 13.63±15.76 months) for the TCGA training dataset. In addition, the correlation between overall survival and the two groups was significant (P=0.0049). For the validation dataset GSE62254, the low-risk group (mean overall survival time, 57.13±30.88 months; mean progression-free survival time, 42.34±30.26 months) also had a greater overall survival time and progression-free survival time relative to the high-risk group (mean overall survival time, 46.98±29.97 months; mean progression-free survival time, 30.91±27.97 months). Similarly, the two groups were significantly correlated with overall survival time (P=0.0251) and progression-free survival time (P=0.0006). Additionally, the associations between the risk score and survival status/lncRNA expression are displayed in [Fig. 6](#f6-ol-0-0-10124){ref-type="fig"}. The risk score altered from low to high on the vertical axis; in the middle panels, red represents mortality, and black represents survival, which represented the distribution of mortality and survival at high and low risk in addition to the distribution of survival time. [Fig. 6](#f6-ol-0-0-10124){ref-type="fig"} reveals the expression trend of 5 genes from low risk to high risk (for example, *LINC00307* expression tends to be decreased, while *KCNQ1DN* expression tends to be increased).

### Differential expression analysis

There were a total of 1,105 consensus DE-RNAs (all were mRNAs) in the GSE65801, GSE29998, GSE33335 and GSE27342 datasets, including 22 mRNAs (2 upregulated and 20 downregulated) in the green module. The clustering heat map demonstrates that the different degrees and dysregulation directions of the DE-RNAs were essentially the same in the 4 datasets ([Fig. 7](#f7-ol-0-0-10124){ref-type="fig"}).

### Analysis of lncRNA-associated pathways

Based on the correlation coefficients of the 5 optimal lncRNAs in the green module, and the 22 mRNAs obtained as aforementioned, the lncRNA-mRNA network (involving 106 nodes) was constructed ([Fig. 8A](#f8-ol-0-0-10124){ref-type="fig"}). GSEA analysis illustrated that 4 pathways \['cell adhesion molecules (CAMS)', 'cytokine-cytokine receptor interaction', the 'chemokine signaling pathway' and 'leukocyte transendothelial migration'\] had significant positive associations with 3 lncRNAs (*LINC00167, LINC00173* and *LINC00307*) ([Table IV](#tIV-ol-0-0-10124){ref-type="table"}). Moreover, the 4 pathways involved a total of 32 genes \[including chemokine (C-C motif) ligand 22 (*CCL22*), chemokine (C-C motif) receptor 7 (*CCR7*), cluster of differentiation (CD) 274 molecule (*CD274*), CD40 ligand (*CD40LG*), chemokine (C-X-C motif) ligand 13, *CXCL13*; chemokine (C-X-C motif) receptor 5 (*CXCR5*), intercellular adhesion molecule 1 (*ICAM1*), matrix metalloproteinase 9 (*MMP9*) and vascular cell adhesion molecule 1 (*VCAM1*)\], and these genes associated positively with the 4 pathways ([Fig. 8B](#f8-ol-0-0-10124){ref-type="fig"}). Therefore, it was speculated that *LINC00167, LINC00173* and *LINC00307* may possess the same association directions with the 4 pathways and the 32 genes, and are involved in GC progression via these pathways.

Discussion
==========

In the present study, 5 stable modules (blue, green, red, turquoise and yellow) were identified using WGCNA. In particular, the green and turquoise modules associated significantly with histological grade. Subsequently, 12 prognosis-associated lncRNAs (5 lncRNAs in the green module and seven lncRNAs in the turquoise module) were identified. Moreover, 5-lncRNA, 5-lncRNA and 8-lncRNA optimal combinations were screened separately from the prognosis-associated lncRNAs in the green, turquoise and green + turquoise modules, respectively, which were used to construct risk score systems. Notably, the risk score system based on the optimal lncRNA combination (including *ITPK1-AS1, KCNQ1DN, LINC00167, LINC00173* and *LINC00307*) of the green module had the most significant predictive effect and was thus identified as the optimal system. Differential expression analysis indicated that there were 1,105 consensus DE-RNAs in the GSE65801, GSE29998, GSE33335 and GSE27342 datasets. Following the construction of the lncRNA-mRNA network, 4 pathways had significantly positive associations with *LINC00167, LINC00173* and *LINC00307*. Moreover, the 32 genes involved in the 4 pathways associated positively with the pathways.

Potassium voltage-gated channel subfamily E regulatory subunit 2 (*KCNE2*) is the β subunit of potassium voltage-gated channel subfamily Q member 1 (KCNQ1) in gastric parietal cells, and KCNQ1/KCNE2 is activated (accompanied with acid secretion) by certain pathways ([@b50-ol-0-0-10124],[@b51-ol-0-0-10124]). Through mediating the expression of *KCNQ1*, atrial natriuretic peptide serves a role in the proliferation of the GC AGS cell line ([@b52-ol-0-0-10124]). *KCNQ1* and insulin-like growth factor 2 mRNA-binding protein 2 polymorphisms may serve as independent predictive factors for chemotherapeutic response, and glucokinase (hexokinase 4) regulator polymorphisms may independently predict the survival of patients with metastatic GC ([@b53-ol-0-0-10124]). The KCNQ1 protein level was decreased in colorectal cancer samples, and was associated significantly with the unfavorable overall survival of patients with colorectal cancer ([@b54-ol-0-0-10124]). These observations demonstrated that *KCNQ1DN* may be involved in the prognosis of GC.

*CCL22* functions in the development of GC by increasing the number of regulatory T cells, and *CCL22* levels in sera predict the metastasis and recurrence of GC ([@b55-ol-0-0-10124]). *CCR7* causes epithelial-mesenchymal transition by promoting Snail expression, which results in the migration and invasion of GC cells ([@b56-ol-0-0-10124],[@b57-ol-0-0-10124]). A somatic mutation in *CD274* induces its overexpression by disturbing *miR-570* binding, and subsequently promotes immune evasion in GC by suppressing the activation and proliferation of T cells ([@b58-ol-0-0-10124]). The expression level of *CXCL13* is a promising prognostic marker for patients with GC following surgical resection, and may be used to predict the response of these patients to postoperative adjuvant chemotherapy ([@b59-ol-0-0-10124]). *CD40* contributes to *CXCR5* expression, and the migration and accumulation of myeloid-derived suppressor cells in GC, indicating that *CD40* may promote tumor growth by influencing immune evasion ([@b60-ol-0-0-10124],[@b61-ol-0-0-10124]). *ICAM1* overexpression is induced by leptin via the Rho/Rho-associated protein kinase pathway, which contributes to tumor cell migration in patients with GC ([@b62-ol-0-0-10124]). *MMP9* in the blood has been identified as a novel tumor marker; in particular, the plasma level of *MMP9* is a more effective predictor of GC development and progression compared with its serum level ([@b63-ol-0-0-10124],[@b64-ol-0-0-10124]). *VCAM1* functions in the perineural invasion (PNI) of GC by mediating the interaction between tumor cells and neural cells; therefore, *VCAM1* inhibition suggests a promising approach for the treatment of PNI in patients with GC ([@b65-ol-0-0-10124]). *LINC00167, LINC00173* and *LINC00307* had the same association directions with the 4 pathways and 32 genes (including *CCL22, CCR7, CD274, CD40LG, CXCL13, CXCR5, ICAM1, MMP9* and *VCAM1*), suggesting that *LINC00167, LINC00173* and *LINC00307* may associate positively with GC through their participation in the 4 pathways, and by mediating the expression of these genes.

Certain limitations of the present study should be considered. Bioinformatics analyses were used to obtain these results, and no experimental research was performed. Platform differences and data heterogeneities of the datasets may have influenced the accuracy of the risk score system. Therefore, further experiments are required to confirm the results.

In conclusion, 12 prognosis-associated lncRNAs were identified from the green and turquoise modules. In addition, the optimal risk score system may be used to predict the prognosis of patients with GC. lncRNAs *ITPK1-AS1, KCNQ1DN, LINC00167, LINC00173* and *LINC00307* may serve important roles in the pathogenesis of GC.
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![The correlation analysis of the datasets. (A) Expression correlations and (B) connection correlations between the RNAs of every two entries of TCGA dataset, GSE15459 and GSE54129. Left, middle, and right diagrams represent TCGA-GSE15459, TCGA-GSE54129 and GSE15459-GSE54129, respectively. TCGA, The Cancer Genome Atlas; GSE, gene set enrichment.](ol-17-05-4474-g00){#f1-ol-0-0-10124}

![Selection diagram of the adjacency matrix weighting parameter 'power'. (A) The red line is the standard when the square of the correlation coefficient reaches 0.9. (B) The mean connectivity of RNAs under different values of 'power' (the red line represents the mean connectivity of 2 when the power is 6).](ol-17-05-4474-g01){#f2-ol-0-0-10124}

![Module partition trees of datasets. (A) TCGA dataset, (B) GSE15459 and (C) GSE54129. Modules are indicated by different colors. TCGA, The Cancer Genome Atlas; GSE, gene set enrichment.](ol-17-05-4474-g02){#f3-ol-0-0-10124}

![The association analysis of the gene modules and clinical features. (A) Multidimensional extension plot of the RNAs in each module. The horizontal and vertical axes separately represent the first and second principal components. (B) Module dendrogram of the seven modules. (C) Correlation heat map between each module and clinical factors; the horizontal and vertical axes separately represent clinical factors and modules; the change of color from green to red indicates the change of correlation from negative to positive; the numbers in grids represent correlation coefficients, and the numbers in parentheses represent significant P-values. ME, module eigengene; MDS, multidimensional scaling; TNM, Tumor Node Metastasis.](ol-17-05-4474-g03){#f4-ol-0-0-10124}

![Kaplan-Meier survival curves of the correlations between patient survival and the risk grouping based on the risk score systems of the modules. (A) green, (B) turquoise and (C) green + turquoise modules. Left, middle and right curves represent the overall survival time of TCGA dataset, the overall survival time of GSE62254 and the progression-free survival time of GSE62254, respectively. The black and blue lines represent the low-risk group, and the red and purple lines represent the high-risk group. TCGA, The Cancer Genome Atlas; GSE, gene set enrichment.](ol-17-05-4474-g04){#f5-ol-0-0-10124}

![Associations between risk score and survival status and/or lncRNA expression in the datasets. (A) the training set and (B), the validation set. A1 and B1 represents the risk score: The horizontal axis represents the sample and the vertical axis represents the risk score. A2 and B2 represents survival status: The horizontal axis represents the sample and the vertical axis represents the survival time. A3 and B3 represents the expression levels of 5 lncRNAs: The horizontal axis represents the sample and the vertical axis represents the expression level of the gene. Red means high expression; green stands for low expression. lncRNA, long non-coding RNA; *ITPK1-AS1*, ITPK1 antisense RNA 1; *KCNQ1DN*, KCNQ1 downstream neighbor; *LINC00167*, long intergenic non-protein coding RNA 167.](ol-17-05-4474-g05){#f6-ol-0-0-10124}

![Clustering heat maps of the consensus differentially expressed RNAs in the GSE27342, GSE29998, GSE65801 and GSE33335 datasets. Black and white represent tumor and control samples, respectively. Red means high expression; green stands for low expression. GSE, gene set enrichment.](ol-17-05-4474-g06){#f7-ol-0-0-10124}

![(A) lncRNA-mRNA network and gene heat map. The lncRNA-mRNA network is based on the green module. Grey circles represent non-consensus differentially expressed RNAs. Red regular triangles and green inverted triangles represent upregulated RNAs and downregulated RNAs, respectively. Green squares represent the 5 optimal lncRNAs in the green module. Red and green lines represent positive and negative correlations, respectively. (B) Heat map of the genes involved in the lncRNA-associated pathways. The deeper the red, the higher the positive correlation. lncRNA, long non-coding RNA; *ITPK1-AS1*, ITPK1 antisense RNA 1; *KCNQ1DN*, KCNQ1 downstream neighbor; *LINC00167*, long intergenic non-protein coding RNA 167.](ol-17-05-4474-g07){#f8-ol-0-0-10124}

###### 

Differentially expressed lncRNAs between the tumor and control groups in 7 modules.

  Group             Module      P-value        FDR            logFC
  ----------------- ----------- -------------- -------------- ---------
  *HOTAIR*          Blue        1.01×10^−55^   1.46×10^−53^   5.2805
  *MCF2L-AS1*       Blue        2.58×10^−15^   3.74×10^−14^   0.9188
  *GAS5*            Brown       8.85×10^−7^    3.38×10^−6^    0.1977
  *CASC2*           Green       5.41×10^−11^   3.92×10^−10^   0.7532
  *CECR3*           Green       2.06×10^−11^   1.66×10^−10^   2.8280
  *CPS1-IT1*        Green       1.58×10^−2^    2.48×10^−2^    1.2022
  *HCG27*           Green       2.35×10^−3^    4.49×10^−3^    0.3698
  *IGF2-AS*         Green       3.12×10^−6^    1.08×10^−5^    2.2240
  *INHBA-AS1*       Green       1.85×10^−2^    2.86×10^−2^    0.9693
  *JAZF1-AS1*       Green       6.36×10^−3^    1.12×10^−2^    −0.5507
  *KCNQ1DN*         Green       1.59×10^−2^    2.48×10^−2^    1.8214
  *LINC00032*       Green       3.31×10^−3^    6.15×10^−3^    0.8562
  *LINC00112*       Green       1.50×10^−2^    2.42×10^−2^    2.1061
  *LINC00115*       Green       1.66×10^−10^   1.09×10^−9^    0.7638
  *LINC00163*       Green       2.81×10^−2^    4.16×10^−2^    −1.2973
  *LINC00167*       Green       7.42×10^−4^    1.58×10^−3^    0.5133
  *LINC00242*       Green       1.84×10^−6^    6.67×10^−6^    0.6465
  *LINC00299*       Green       2.20×10^−16^   3.99×10^−15^   1.8836
  *LINC00326*       Green       1.72×10^−3^    3.47×10^−3^    4.7055
  *LINC00330*       Green       1.28×10^−2^    2.12×10^−2^    −1.9390
  *LINC00410*       Green       4.51×10^−7^    1.92×10^−6^    4.2579
  *LINC00485*       Green       2.56×10^−7^    1.12×10^−6^    2.6578
  *LINC00486*       Green       3.22×10^−4^    8.06×10^−4^    1.6764
  *LINC00523*       Green       1.59×10^−3^    3.29×10^−3^    3.1421
  *LINC00607*       Green       5.97×10^−7^    2.40×10^−6^    1.4066
  *WDFY3-AS2*       Green       6.90×10^−4^    1.54×10^−3^    −0.4393
  *ADARB2-AS1*      Grey        1.52×10^−4^    4.09×10^−4^    2.0305
  *TP53TG1*         Grey        5.11×10^−6^    1.65×10^−5^    −0.2026
  *TTTY14*          Grey        4.86×10^−4^    1.12×10^−3^    −1.0856
  *AGPAT4-IT1*      Red         5.75×10^−6^    1.77×10^−5^    0.8612
  *BPESC1*          Red         1.12×10^−3^    2.35×10^−3^    1.7243
  *BVES-AS1*        Red         1.82×10^−4^    4.71×10^−4^    −1.6299
  *DGCR5*           Red         6.81×10^−15^   8.98×10^−14^   1.7023
  *DSCR9*           Red         8.94×10^−14^   1.08×10^−12^   1.1941
  *EPB41L4A-AS1*    Red         3.87×10^−2^    5.51×10^−2^    −0.0787
  *HCG18*           Red         1.24×10^−12^   1.20×10^−11^   0.4696
  *LINC00029*       Red         2.01×10^−3^    3.94×10^−3^    1.7851
  *LINC00467*       Red         1.06×10^−10^   7.32×10^−10^   0.4418
  *LINC00470*       Red         5.90×10^−6^    1.78×10^−5^    1.6068
  *LINC00487*       Red         2.29×10^−2^    3.49×10^−2^    0.9837
  *LINC00574*       Red         8.80×10^−5^    2.45×10^−4^    0.7952
  *MAGI2-AS3*       Red         3.00×10^−2^    4.35×10^−2^    −0.4123
  *MIR17HG*         Red         2.02×10^−27^   4.18×10^−26^   1.5489
  *MORC2-AS1*       Red         3.08×10^−16^   4.96×10^−15^   0.5989
  *SHANK2-AS3*      Red         1.49×10^−8^    8.00×10^−8^    1.6254
  *TTTY13*          Red         7.02×10^−4^    1.54×10^−3^    2.8019
  *ASMTL-AS1*       Turquoise   2.97×10^−12^   2.69×10^−11^   0.6011
  *C20orf166-AS1*   Turquoise   3.52×10^−4^    8.64×10^−4^    −1.8050
  *CCDC26*          Turquoise   6.66×10^−3^    1.15×10^−2^    0.9937
  *CIRBP-AS1*       Turquoise   2.95×10^−9^    1.71×10^−8^    0.6040
  *CRNDE*           Turquoise   2.43×10^−3^    4.58×10^−3^    0.4485
  *CSNK1G2-AS1*     Turquoise   3.76×10^−9^    2.10×10^−8^    1.2461
  *CYP1B1-AS1*      Turquoise   2.36×10^−3^    4.49×10^−3^    −0.7444
  *DSCR10*          Turquoise   5.40×10^−4^    1.22×10^−3^    3.0388
  *ENO1-AS1*        Turquoise   1.73×10^−4^    4.56×10^−4^    0.4499
  *FBXL19-AS1*      Turquoise   3.49×10^−32^   1.01×10^−30^   0.9572
  *JPX*             Turquoise   3.27×10^−5^    9.30×10^−5^    0.2466
  *LGALS8-AS1*      Turquoise   1.04×10^−6^    3.87×10^−6^    0.4645
  *LINC00052*       Turquoise   2.46×10^−6^    8.70×10^−6^    3.7146
  *LINC00161*       Turquoise   4.63×10^−4^    1.08×10^−3^    0.9597
  *LINC00189*       Turquoise   2.11×10^−8^    1.09×10^−7^    1.2475
  *LINC00290*       Turquoise   2.47×10^−2^    3.73×10^−2^    2.6024
  *LINC00308*       Turquoise   4.33×10^−3^    7.85×10^−3^    2.1851
  *LINC00309*       Turquoise   2.65×10^−4^    6.75×10^−4^    2.2938
  *LINC00311*       Turquoise   1.32×10^−2^    2.14×10^−2^    0.6300
  *LINC00323*       Turquoise   6.57×10^−3^    1.15×10^−2^    0.5396
  *LINC00347*       Turquoise   1.63×10^−3^    3.32×10^−3^    2.4716
  *LINC00471*       Turquoise   3.59×10^−6^    1.18×10^−5^    1.0278
  *LINC00477*       Turquoise   4.83×10^−3^    8.64×10^−3^    1.4857
  *LINC00479*       Turquoise   4.59×10^−4^    1.08×10^−3^    1.1469
  *LINC00482*       Turquoise   1.02×10^−4^    2.80×10^−4^    0.8407
  *LINC00518*       Turquoise   6.17×10^−8^    2.98×10^−7^    2.5336
  *LINC00582*       Turquoise   4.52×10^−4^    1.08×10^−3^    −1.5306
  *NBR2*            Turquoise   1.03×10^−9^    6.49×10^−9^    0.3945
  *NEAT1*           Turquoise   1.19×10^−5^    3.45×10^−5^    0.2762
  *NPSR1-AS1*       Turquoise   9.94×10^−31^   2.40×10^−29^   5.6701
  *PCBP1-AS1*       Turquoise   3.37×10^−8^    1.69×10^−7^    −0.4557
  *RUSC1-AS1*       Turquoise   7.90×10^−7^    3.10×10^−6^    0.1934
  *ST7-AS2*         Turquoise   5.65×10^−6^    1.77×10^−5^    0.2453
  *ZNF295-AS1*      Turquoise   1.89×10^−3^    3.74×10^−3^    1.0881
  *ZNF503-AS2*      Turquoise   2.98×10^−2^    4.35×10^−2^    −0.1638
  *C20orf203*       Yellow      3.31×10^−2^    4.75×10^−2^    0.7754
  *DLEU2*           Yellow      1.01×10^−35^   4.88×10^−34^   1.0471
  *FAM201A*         Yellow      1.42×10^−9^    8.58×10^−9^    0.8587
  *FAM66C*          Yellow      1.54×10^−2^    2.45×10^−2^    −0.5395
  *HCG4B*           Yellow      2.42×10^−7^    1.10×10^−6^    1.1311
  *HCG9*            Yellow      7.28×10^−3^    1.24×10^−2^    0.5412
  *HCP5*            Yellow      3.42×10^−6^    1.15×10^−5^    0.4477
  *INE1*            Yellow      4.51×10^−12^   3.85×10^−11^   0.8886
  *KIF25-AS1*       Yellow      1.51×10^−7^    7.06×10^−7^    1.7721
  *LINC00174*       Yellow      2.83×10^−13^   2.93×10^−12^   0.8178
  *LINC00265*       Yellow      4.80×10^−7^    1.99×10^−6^    0.5363
  *LINC00599*       Yellow      9.87×10^−3^    1.66×10^−2^    1.5708
  *LINC00606*       Yellow      1.28×10^−2^    2.12×10^−2^    4.1423
  *LY86-AS1*        Yellow      7.20×10^−4^    1.56×10^−3^    1.2773
  *PART1*           Yellow      6.79×10^−6^    2.01×10^−5^    −1.5909
  *RHPN1-AS1*       Yellow      6.31×10^−33^   2.29×10^−31^   1.5361
  *SND1-IT1*        Yellow      1.31×10^−13^   1.46×10^−12^   1.1209
  *SOX2-OT*         Yellow      2.75×10^−2^    4.11×10^−2^    −0.4175
  *TP73-AS1*        Yellow      4.11×10^−3^    7.55×10^−3^    −0.3515
  *TUG1*            Yellow      3.08×10^−11^   2.35×10^−10^   0.2871
  *ZNF252P-AS1*     Yellow      4.75×10^−37^   3.44×10^−35^   1.4731

Differentially expressed lncRNAs were screened using the MetaDE.ES algorithm in the R package MetaDE (version 1.0.5; <http://cran.r-project.org/web/packages/MetaDE/>), P\<0.05 and FDR\<0.05 were set as the cut-off criteria. FDR, false discovery rate; FC, fold-change.

###### 

Stabilities and functional annotations of the 7 modules of TCGA dataset.

  Module   Color       Module size, n   mRNA    lncRNA   Preservation Z-score   Module annotation
  -------- ----------- ---------------- ------- -------- ---------------------- -------------------------------
  1        Blue        336              334     2        9.7094                 Pattern specification process
  2        Brown       331              328     3        1.2017                 Epithelium development
  3        Green       318              288     30       19.0215                Immune response
  4        Grey        2,856            2,822   34       4.2851                 Cell-cell signaling
  5        Red         250              213     37       13.2273                Digestive system process
  6        Turquoise   956              910     46       27.4163                Cell adhesion
  7        Yellow      326              294     32       15.7692                Digestion

Z\<5 indicates that the module is unstable; Z\>5 indicates that the module is stable, and Z\>10 indicates that the module is highly stable. Module annotation indicates the functional terms enriched for the modules. TCGA, The Cancer Genome Atlas; lncRNA, long non-coding RNA.

###### 

Optimal lncRNAs screened from the prognosis-associated lncRNAs in green, turquoise and green + turquoise modules.

  Modules             lncRNA        *β*-value   P-values   Hazard ratio (95% CI)
  ------------------- ------------- ----------- ---------- ---------------------------
  Green               *ITPK1-AS1*   −0.9059     0.0496     0.0777 (0.0039--1.5300)
                      *KCNQ1DN*     3.3538      0.0050     13.7200 (2.1360--18.1400)
                      *LINC00167*   −2.1388     0.0284     0.0500 (0.0035--0.7191)
                      *LINC00173*   −1.0376     0.0480     0.4930 (0.2229--1.0900)
                      *LINC00307*   1.9587      0.0357     2.0260 (1.0430--3.9380)
  Turquoise           *ASMTL-AS1*   −0.2684     0.0270     0.6392 (0.4302--0.9498)
                      *CIRBP-AS1*   −0.3410     0.0458     0.6489 (0.4146--1.0160)
                      *DSCR10*      1.0927      0.0039     4.4030 (1.5400--12.5900)
                      *JPX*         −0.3433     0.0470     0.6624 (0.4243\~1.0340)
                      *LINC00479*   0.5437      0.0231     1.9880 (1.0900--3.6260)
  Green + turquoise   *KCNQ1DN*     1.9686      0.0029     3.3500 (1.3101--5.3910)
                      *LINC00167*   −0.6567     0.0476     0.0790 (0.0048--1.3100)
                      *LINC00173*   −0.4293     0.0482     0.4338 (0.1693--1.1110)
                      *ASMTL-AS1*   −0.2461     0.0238     0.7758 (0.5088--1.1830)
                      *CIRBP-AS1*   −0.2575     0.0489     0.8482 (0.5322--1.3520)
                      *DSCR10*      0.7023      0.0208     2.2280 (1.6399--7.7580)
                      *JPX*         −0.3204     0.0131     0.6847 (0.4187--1.1200)
                      *LINC00479*   0.5495      0.0337     1.9057 (1.0510--3.4550)

P-values were generated by univariate cox regression, with P\<0.05 as the threshold. lncRNA, long non-coding RNA; CI, confidence interval.

###### 

Pathways that positively correlate with *LINC00167, LINC00173* and *LINC00307*.

                                           *LINC00167*   *LINC00173*   *LINC00307*                                                  
  ---------------------------------------- ------------- ------------- ------------- -------- -------- -------- --------- --------- --------
  Cell adhesion molecules                  0.1598        1.1790        0.0096        0.1654   1.3800   0.0011   0.1465    0.8646    0.0058
  Cytokine-cytokine receptor interaction   0.2250        0.9947        0.0451        0.2052   1.0447   0.0357   0.1136    0.7058    0.0484
  Chemokine signaling pathway              0.2305        1.0060        0.0429        0.1052   0.5347   0.0469   −0.1560   −1.0490   0.0335
  Leukocyte transendothelial migration     −0.1690       −0.7141       0.0461        0.2331   0.1563   0.0137   −0.1860   −0.7750   0.0480

P-values were generated by GSEA analysis, with P\<0.05 as the threshold. ES, enrichment score; NES, normalized enrichment score.
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